Clincosm LogoSign in Get a demo

Cancer

Showing NaN - NaN of 78
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer, Solid Tumor Trial in San Antonio (Eribulin, Lenvatinib)

Unknown status
  • Cancer
  • Solid Tumor
  • San Antonio, Texas
    Cancer Therapy and Research Center University of Texas Health Sc
Mar 1, 2021

Renal Cell Carcinoma (RCC), Cancer Trial in Worldwide (pazopanib, )

Completed
Has Results
  • Renal Cell Carcinoma (RCC)
  • Cancer
  • Jonesboro, Arkansas
  • +311 more
Oct 29, 2020

Cancer Trial in Indianapolis, Grand Rapids, San Antonio (APX3330)

Completed
  • Cancer
  • Indianapolis, Indiana
  • +2 more
Sep 3, 2020

Cancer, Malignancy, Neoplasia Trial in United States (ASN007: ascending doses, ASN007 RD)

Completed
  • Cancer
  • +18 more
  • ASN007: ascending doses
  • ASN007 RD
  • Tampa, Florida
  • +4 more
Jul 7, 2020

Progressive Solid Malignancies, Refractory Solid Malignancies, Cancer Trial in San Antonio (TAPA-pulsed DC vaccine,

Terminated
Has Results
  • Progressive Solid Malignancies
  • +2 more
  • TAPA-pulsed DC vaccine
  • +2 more
  • San Antonio, Texas
    (unnamed)
Apr 14, 2020

Cancer Trial in United States (LYC-55716)

Completed
  • Cancer
  • Huntsville, Alabama
  • +19 more
Sep 24, 2019

Cancer Trial in Canada, United States (Lapatinib, Trastuzumab)

Terminated
Has Results
  • Cancer
  • Chandler, Arizona
  • +115 more
Jun 5, 2019

Cancer Trial in Worldwide (GSK2118436, GSK1120212, Other approved anti-cancer agent)

Completed
  • Cancer
  • Goodyear, Arizona
  • +43 more
Mar 20, 2019

Cancer Trial in Worldwide (GSK1120212, Docetaxel + GSK1120212, Erlotinib + GSK1120212)

Terminated
Has Results
  • Cancer
  • Goodyear, Arizona
  • +18 more
Feb 17, 2019

Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Lymphoma, Follicular Trial in Argentina, United States (ASN002 Dose

Terminated
  • Lymphoma, Large B-Cell, Diffuse
  • +20 more
  • ASN002 Dose Escalation
  • ASN002 RD
  • Tempe, Arizona
  • +13 more
Aug 13, 2018

Cancer Trial in United States (ofatumumab, bendamustine)

Completed
  • Cancer
  • Birmingham, Alabama
  • +4 more
Feb 27, 2018

Cancer Trial in Detroit, San Antonio (CUDC-101)

Terminated
  • Cancer
  • Detroit, Michigan
  • +1 more
Feb 8, 2018

Cancer Trial in Dallas, San Antonio (GSK1120212, GSK2110183)

Completed
  • Cancer
  • Dallas, Texas
  • +1 more
Nov 8, 2017

Cancer Trial in Australia, United Kingdom, United States (GSK2118436 75 mg, Placebo)

Completed
  • Cancer
  • GSK2118436 75 mg
  • Placebo
  • Scottsdale, Arizona
  • +7 more
Nov 8, 2017

Cancer Trial in San Antonio, Salt Lake City (GSK1120212)

Completed
  • Cancer
  • San Antonio, Texas
  • +1 more
Nov 8, 2017

Cancer Trial in Detroit, Nashville, San Antonio (GSK1120212)

Completed
  • Cancer
  • Detroit, Michigan
  • +2 more
Nov 8, 2017

Cancer Trial in United States (GSK1120212, GSK2141795)

Completed
  • Cancer
  • Aurora, Colorado
  • +9 more
Nov 8, 2017

Cancer Trial in Nashville, San Antonio, Paris Cedex 20 (GSK1120212 plus everolimus)

Completed
  • Cancer
  • GSK1120212 plus everolimus
  • Nashville, Tennessee
  • +2 more
Nov 7, 2017

Cancer, Cataract, Low Bone Mineral Density Trial in Worldwide (Denosumab, Placebo)

Completed
Has Results
  • Cancer
  • +5 more
  • Denosumab
  • Placebo
  • Anaheim, California
  • +171 more
Apr 19, 2017

Cancer, Lymphoma, Prostate Cancer Trial in San Antonio (PNT2258)

Completed
  • Cancer
  • +3 more
  • San Antonio, Texas
    South Texas Accelerated Research Therapeutics (START)
Jan 20, 2017

Cancer Trial in United States (Custirsen, paclitaxel and carboplatin)

Completed
  • Cancer
  • Custirsen, paclitaxel and carboplatin
  • Detroit, Michigan
  • +3 more
Oct 7, 2016

Cancer Trial in United States (Birinapant)

Completed
Has Results
  • Cancer
  • Fort Lauderdale, Florida
  • +6 more
Apr 21, 2016

Melanoma, Cancer Trial in Canada, United States (ALVAC(2) Melanoma multi-antigen therapeutic vaccine, Intron A, Interferon alpha

Terminated
Has Results
  • Melanoma
  • Cancer
  • ALVAC(2) Melanoma multi-antigen therapeutic vaccine
  • Intron A, Interferon alpha -2b
  • Tucson, Arizona
  • +18 more
Apr 12, 2016

Cancer Trial in Philadelphia, San Antonio (XL888)

Terminated
  • Cancer
  • Philadelphia, Pennsylvania
  • +1 more
Aug 19, 2015

Cancer, Non-small-cell Lung Cancer, Breast Cancer Trial in New York City, San Antonio (XL647, XL147)

Withdrawn
  • Cancer
  • +2 more
  • New York City, New York
  • +1 more
Aug 19, 2015